Middle East And Africa Corneal Transplant Market
Tamanho do mercado em biliões de dólares
CAGR : %
Período de previsão |
2024 –2031 |
Tamanho do mercado (ano base ) | USD 21.86 Million |
Tamanho do mercado ( Ano de previsão) | USD 31.28 Million |
CAGR |
|
Principais participantes do mercado |
Mercado de transplante de córnea no Médio Oriente e África, por tipo de procedimento (queratoplastia endotelial, queratoplastia penetrante, queratoplastia lamelar anterior (ALK), transplante de células estaminais límbicas da córnea, transplante de córnea artificial e outros), tipo (córnea humana e sintética), tipo de dador ( Autoenxerto e Aloenxerto), Tipo de Enxerto (Enxertos de Espessura Parcial (Lamelar) e Enxertos de Espessura Total (Penetrante)), Tipo de Cirurgia (Cirurgia Convencional, Cirurgia Assistida por Laser), Indicação (Distrofia Endotelial de Fuch, Ceratite Infecciosa, Ceratopatia Bolhosa, Ceratocone, Reenxerto Procedimentos, cicatrizes de córnea, úlceras de córnea e outros), género (feminino e masculino), faixa etária (geriátrica, adulta e pediátrica), utilizador final (hospitais, clínicas oftalmológicas , centros de cirurgia ambulatória, institutos académicos e de investigação e outros) - Tendências e previsões da indústria para 2031
Análise e dimensão do mercado de transplante de córnea no Médio Oriente e África
O mercado de implantes de córnea no Médio Oriente e em África é impulsionado por vários fatores, incluindo a crescente prevalência de doenças da córnea, um crescente envelhecimento da população, avanços na tecnologia, aumento da procura de procedimentos minimamente invasivos, aumento da consciencialização sobre o transplante de córnea, iniciativas governamentais e financiamento, aumento adoção de lentes híbridas e tóricas, popularidade crescente de procedimentos de cross-linking, expansão das indicações para implantes de córnea e um cenário competitivo que promove a inovação. Estes factores estão a impulsionar colectivamente a procura de implantes de córnea, particularmente nos países desenvolvidos, à medida que os pacientes procuram tratamentos eficazes para distúrbios e condições de visão como o ceratocone, a distrofia de Fuchs e a ceratopatia bolhosa pseudofácica.
A Data Bridge Market Research analisa que o mercado de transplante de córnea do Médio Oriente e África deverá atingir os 31,28 milhões de dólares até 2031, contra 21,86 milhões de dólares em 2023, crescendo com um CAGR de 4,6% no período previsto de 2024 a 2031.
Métrica de reporte |
Detalhes |
Período de previsão |
2024 a 2031 |
Ano base |
2023 |
Anos históricos |
2022 (personalizável 2016-2021) |
Unidades Quantitativas |
Receita em milhões de dólares |
Segmentos cobertos |
Tipo de procedimento (queratoplastia endotelial, queratoplastia penetrante, queratoplastia lamelar anterior (ALK), transplante de células estaminais límbicas da córnea, transplante de córnea artificial e outros), tipo (córnea humana e sintética), tipo de dador (autoenxerto e aloenxerto) , tipo de enxerto (parcial Enxertos de espessura (lamelar) e enxertos de espessura total (penetrantes), tipo de cirurgia (cirurgia convencional, cirurgia assistida por laser), indicação (distrofia endotelial de Fuch, queratite infecciosa, queratopatia bolhosa, queratocone, procedimentos de reenxerto, cicatrizes da córnea, úlceras da córnea e Outros), Sexo (feminino e masculino), Faixa etária (geriátrica, adulta e pediátrica), Utilizador final (hospitais, clínicas oftalmológicas, centros de cirurgia ambulatória , institutos académicos e de investigação e outros ) |
Países abrangidos |
África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egipto, Israel, Resto do Médio Oriente e África. |
Participantes do mercado abrangidos |
Grupo ZEISS (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., entre outros. |
Definição de mercado
O mercado de transplante de córnea refere-se à área médica focada em procedimentos cirúrgicos que substituem córneas danificadas ou doentes por tecido de dador saudável. Os transplantes de córnea, também conhecidos como queratoplastia, são realizados para restaurar a visão em pacientes que sofrem de doenças como o queratocone, cicatrizes na córnea, infeções ou disfunção endotelial da córnea. O mercado abrange vários tipos de procedimentos de transplante, incluindo a ceratoplastia penetrante (transplante de córnea de espessura total) e a ceratoplastia endotelial (transplante de espessura parcial), e é apoiado por avanços nas técnicas cirúrgicas, disponibilidade de tecidos doadores e melhores cuidados pós-operatórios . À medida que as doenças oculares se tornam mais prevalentes a nível mundial, e com as inovações tecnológicas que aumentam a taxa de sucesso das cirurgias, o mercado de transplante de córnea continua a crescer, respondendo à crescente procura de restauração da visão.
Dinâmica do mercado de transplante de córnea no Médio Oriente e em África:
Esta secção trata da compreensão dos impulsionadores do mercado, vantagens, oportunidades, restrições e desafios. Tudo isto é discutido em detalhe abaixo:
Motoristas
- Aumento da prevalência de doenças oculares
A crescente prevalência de doenças oculares é um factor significativo no mercado de transplante de córnea no Médio Oriente e em África, uma vez que condições como o queratocone, a distrofia endotelial de Fuchs e as cicatrizes na córnea devido a infecções ou traumatismos estão a tornar-se mais comuns. Estas doenças podem levar a graves deficiências visuais ou cegueira, provocando uma procura crescente de transplantes de córnea como tratamento restaurador. O aumento das doenças oculares está frequentemente ligado a factores como o envelhecimento da população, taxas mais elevadas de diabetes e aumento da exposição a poluentes ambientais e à radiação UV, que podem danificar a córnea. Além disso, os avanços nas técnicas de diagnóstico estão a levar à deteção precoce destas doenças, permitindo intervenções atempadas, incluindo o transplante de córnea. Além disso, uma maior consciencialização sobre a saúde da córnea e a disponibilidade de técnicas cirúrgicas melhoradas, como a Ceratoplastia Endotelial de Membrana de Descemet (DMEK) e a Ceratoplastia Endotelial Automatizada de Descemet (DSAEK), estão a contribuir para a crescente aceitação dos transplantes de córnea. À medida que a carga das doenças oculares continua a crescer em todo o mundo, espera-se que a necessidade de soluções eficazes como os transplantes de córnea aumente, alimentando o crescimento do mercado.
Por exemplo,
- In June 2023, according to the article published in NCBI, a study was conducted to investigate the prevalence of keratoconus in a large German cohort and to evaluate possible associated factors. Keratoconus appears to be a rare corneal disease with a prevalence previously estimated at 1:2000. However, in recent relatively small studies, a higher prevalence was found. Prevalence is reported from 1: 6000 for US citizens, 1:1000 for Israeli adolescents, up to 1:20 for Saudi-Arabian Children. Newer studies detected prevalence estimates of 1:191 in New Zealand high school students. A prevalence of up to 1:84 was detected for young Australian adults. The prevalence of keratoconus treatment in the German population is approximately tenfold higher than previously reported in the literature using the latest technologies, namely Scheimpflug imaging, which act as a driver in the growth of the market.
Rising Geriatric Population
The rising geriatric population is a key driver in the Middle East and Africa corneal transplant market, as older adults are more susceptible to various eye conditions that can lead to corneal damage and the need for transplants. Age-related eye diseases, such as Fuchs' endothelial dystrophy, bullous keratopathy, and other degenerative corneal disorders, become more prevalent with advancing age, significantly increasing the demand for corneal transplants. Also, older adults are more likely to experience complications from cataract surgery or develop chronic conditions like diabetes, which can further contribute to corneal deterioration. As the Middle East and Africa population ages, the number of individuals requiring corneal transplants is expected to rise, particularly in regions with rapidly aging demographics. This trend is further fueled by increased awareness about the availability and success rates of corneal transplants, as well as advancements in surgical techniques that offer better outcomes and faster recovery times for older patients. As a result, the growing geriatric population is a major factor driving the expansion of the Middle East and Africa corneal transplant market, highlighting the need for accessible and effective treatment options for age-related corneal diseases.
Opportunity
- Rise in Healthcare Infrastructure
The rise in healthcare infrastructure offers significant opportunities for the Middle East and Africa corneal transplant market by expanding access to transplant services. Enhanced infrastructure leads to the establishment of more hospitals and specialized clinics, making corneal transplants more accessible to a broader population. Improved facilities in underserved or rural areas ensure that patients who previously had limited access to specialized eye care can now receive essential transplant services.
Modernized healthcare facilities are equipped with advanced surgical technologies and diagnostic tools, which directly improve the success rates of corneal transplants and minimize complications. Specialized centers within these advanced systems provide focused expertise and resources, further enhancing surgical outcomes and patient care. The increased capacity of these facilities also supports a higher volume of transplant procedures, effectively addressing patient demand and reducing waiting times.
For instance,
- In April 2024, according to the article ‘The Rise of Hospital Infrastructure & Modernization Updates,’ the U.S. boasts of a robust healthcare infrastructure consisting of over 6,000 hospitals and thousands of small clinics, offering more than a million hospital beds to patients. This infrastructure encompasses a variety of essential elements, such as advanced research labs, cutting-edge technology, and a wide range of medical equipment. Moreover, the federal government has been providing funds for the continuous modernization of the country’s healthcare infrastructure
- In August 2023, according to JLL India, India has been welcoming more investments and innovation to deal with future life-threatening diseases and pandemics that, in turn, help in growing the country’s healthcare and life sciences sector
Restraint/Challenge
- The High Cost of Corneal Transplant Surgery
The high cost of corneal transplant surgery acts as a significant restraint on the growth of the Middle East and Africa corneal transplant market by limiting patient access and affordability, particularly in low- and middle-income countries. Corneal transplant procedures, including traditional Penetrating Keratoplasty (PK) and advanced techniques like Descemet’s Membrane Endothelial Keratoplasty (DMEK) or Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), often involve substantial expenses not only for the surgical procedure itself but also for the associated costs of preoperative assessments, postoperative care, medications, and follow-up visits. Also, the cost of obtaining donor corneas, whether through eye banks or commercial sources, further contributes to the financial burden. In many regions, particularly those with limited healthcare infrastructure, these costs are exacerbated by a lack of insurance coverage or inadequate reimbursement policies, making corneal transplants financially inaccessible to a large portion of the population. Furthermore, the need for specialized surgical expertise and advanced equipment increases the overall expense, thereby restricting the availability of these procedures to well-equipped medical centers in urban areas. Consequently, the high costs associated with corneal transplant surgery hinder market growth by reducing the potential patient pool, especially in underserved regions where the burden of corneal diseases is often most significant and access to affordable healthcare is limited.
Recent Developments
- In January 2024, Carl Zeiss India's Medical Technology Division showcased Cataract and Refractive Workflow at Phaco Festival by Nethradhama Super Speciality, Bengaluru. At the Phaco Festival, the spotlight shined on ZEISS's transformative impact on the Cataract and Corneal Refractive Workflows.
- In June 2024, CorneaGen today announces the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes. Developed by CorneaGen in partnership with CTAK LLC and Ziemer, CTAK provides patient ready, gamma-irradiated sterile, non-immunogenic corneal tissue segments, laser cut and customized to patients’ specific cone severity and location
- In January 2024, Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California. Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities.
- In August 2024, ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology
Middle East and Africa Corneal Transplant Market Scope
The Middle East and Africa corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Procedure Type
- Endothelial Keratoplasty
- Penetrating Keratoplasty
- Anterior Lamellar Keratoplasty (ALK)
- Corneal Limbal Stem Cell Transplant
- Artifical Cornea Transplant
- Others
On the basis of procedure type, the market is segmented into endothelial keratoplasty, penetrating keratoplasty, Anterior Lamellar Keratoplasty (ALK), corneal limbal stem cell transplant, artifical cornea transplant and others.
Type
- Human Cornea
- Synthetic
On the basis of type, the market is segmented into human cornea and synthetic.
Donor Type
- Allograft
- Autograft
On the basis of donor type, the market is segmented into allograft and autograft.
Graft Type
- Partial Thickness Grafts (Lamellar)
- Full Thickness Grafts (Penetrating)
On the basis of graft type, the market is segmented into partial thickness grafts (lamellar), full thickness grafts (penetrating).
Surgery Type
- Conventional Surgery
- Laser-Assisted Surgery
On the basis of surgery type, the market is segmented into conventional surgery and laser-assisted surgery.
Indication
- Fuch's Endothelial Dystrophy
- Infectious Keratitis
- Bullous Keratopathy
- Keratoconus
- Regraft Procedures
- Corneal Scarring
- Corneal Ulcers
- Others
On the basis of indication, the market is segmented into fuch's endothelial dystrophy, infectious keratitis, bullous keratopathy, keratoconus, regraft procedures, corneal scarring, corneal ulcers and others.
Gender
- Female
- Male
On the basis of gender, the market is segmented into female and male.
Age Group
- Geriatric
- Adult
- Pediatric
On the basis of age group, the market is segmented into geriatric, adult and pediatric.
End User
- Hospitals,
- Eye Clinics,
- Ambulatory Surgical Centers,
- Academic & Research Institutes
- Others
On the basis of end user, the market is segmented into hospitals, eye clinics, ambulatory surgical centers, academic & research institutes and others.
Middle East and Africa Corneal Transplant Market Regional Analysis/Insights
Middle East and Africa corneal transplant market is analyzed, and market size insights and trends are provided based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user as referenced above.
The countries covered in this market report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
South Africa is expected to dominate in the Middle East and Africa market due to its advanced healthcare infrastructure, significant consumer demand for eye treatments, strong pharmaceutical industry, extensive research and development efforts, and well-established distribution networks, making it a hub for innovation.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Corneal Transplant Market Share Analysis
The Middle East and Africa corneal transplant market is segmented into eight notable segments based on procedure type, donor type, graft type, surgery type, indication, gender, age group, and end user.
The Middle East and Africa corneal transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Middle East and Africa corneal transplant market.
Alguns dos principais players que operam no mercado de transplante de córnea no Médio Oriente e em África são o Grupo ZEISS (Carl Zeiss Meditec AG.), a Alcon, a CorneaGen, a Ziemer Ophthalmic Systems AG, a RUMEX International Co., entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA CORNEAL IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO
5.5 SOUTH AMERICA REGULATORY SCENARIO
6 CUSTOMIZATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF EYE DISEASES
7.1.2 RISING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS
7.4 CHALLENGES
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS
7.4.2 LIMITED AWARENESS AND TRAINING
8 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE
8.1 OVERVIEW
8.2 HUMAN CORNEA
8.3 SYNTHETIC
9 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 ENDOTHELIAL KERATOPLASTY
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)
9.3 PENETRATING KERATOPLASTY
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT
9.6 ARTIFICIAL CORNEA TRANSPLANT
9.7 OTHERS
10 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE
10.1 OVERVIEW
10.2 ALLOGRAFT
10.3 AUTOGRAFT
11 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION
11.1 OVERVIEW
11.2 FUCH'S ENDOTHELIAL DYSTROPHY
11.3 INFECTIOUS KERATITIS
11.4 BULLOUS KERATOPATHY
11.5 KERATOCONUS
11.6 REGRAFT PROCEDURES
11.7 CORNEAL SCARRING
11.8 CORNEAL ULCERS
11.9 OTHERS
12 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE
12.1 OVERVIEW
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)
12.2.1 DEEP LAMELLAR GRAFTS
12.2.2 SUPERFICIAL LAMELLAR GRAFTS
12.3 FULL THICKNESS GRAFTS (PENETRATING)
13 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE
13.1 OVERVIEW
13.2 CONVENTIONAL SURGERY
13.3 LASER-ASSISTED SURGERY
14 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER
14.1 OVERVIEW
14.2 FEMALE
14.3 MALE
15 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 EYE CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 ACADEMIC & RESEARCH INSTITUTES
16.6 OTHERS
17 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY REGION
17.1 MIDDLE EAST AND AFRICA
17.1.1 SOUTH AFRICA
17.1.2 SAUDI ARABIA
17.1.3 U.A.E.
17.1.4 EGYPT
17.1.5 ISRAEL
17.1.6 REST OF MIDDLE EAST AND AFRICA
18 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
19 SWOT ANALYSIS
20 COMPANY PROFILES
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ALCON
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 CORNEAGEN
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 ZIEMER OPHTHALMIC SYSTEMS AG
20.4.1 COMPANY SNAPSHOT
20.4.2 COMPANY SHARE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENT
20.5 RUMEX INTERNATIONAL CO.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.6 AJL OPHTHALMIC S.A.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 CORNEAT VISION
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 FLORIDA LIONS EYE BANK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 KERAMED, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 MASSACHUSETTS EYE AND EAR
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 OCL VISION
20.11.1 COMPANY SNAPSHOT
20.11.2 SERVICE PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 OVATION INTERNATIONAL
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 SAN DIEGO EYE BANK
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
Lista de Tabela
TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE
TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION
TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE
TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY
TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE
TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).
TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)
TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE
TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA
TABLE 10 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 MIDDLE EAST AND AFRICA INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 MIDDLE EAST AND AFRICA REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 MIDDLE EAST AND AFRICA CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 MIDDLE EAST AND AFRICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 MIDDLE EAST AND AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 MIDDLE EAST AND AFRICA FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 MIDDLE EAST AND AFRICA LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 MIDDLE EAST AND AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 MIDDLE EAST AND AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 64 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 65 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 66 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 67 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 SOUTH AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 SOUTH AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 SOUTH AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 76 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 77 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 78 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 79 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 SAUDI ARABIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 SAUDI ARABIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 SAUDI ARABIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 88 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 89 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 90 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 91 U.A.E. CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 U.A.E. ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 U.A.E. ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 U.A.E. CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 U.A.E. CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 U.A.E. CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 U.A.E. PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 U.A.E. CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 U.A.E. CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 100 U.A.E. CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 101 U.A.E. CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 102 U.A.E. CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 103 EGYPT CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 EGYPT ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 EGYPT ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 EGYPT CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 EGYPT CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 EGYPT CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 EGYPT PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 EGYPT CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 EGYPT CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 112 EGYPT CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 113 EGYPT CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 114 EGYPT CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 115 ISRAEL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 116 ISRAEL ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 ISRAEL ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 ISRAEL CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 ISRAEL CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 ISRAEL CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 ISRAEL PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 ISRAEL CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 ISRAEL CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 124 ISRAEL CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 125 ISRAEL CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 126 ISRAEL CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 127 REST OF MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
Lista de Figura
FIGURE 1 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 11 SIX SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031
FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2023
FIGURE 18 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)
FIGURE 20 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023
FIGURE 22 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 24 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023
FIGURE 26 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)
FIGURE 27 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)
FIGURE 28 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023
FIGURE 30 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)
FIGURE 31 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)
FIGURE 32 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023
FIGURE 34 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 35 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)
FIGURE 36 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE
FIGURE 37 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023
FIGURE 38 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 39 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)
FIGURE 40 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 41 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2023
FIGURE 42 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)
FIGURE 43 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)
FIGURE 44 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 45 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023
FIGURE 46 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)
FIGURE 47 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 48 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 49 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY END USER, 2023
FIGURE 50 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 51 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 52 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)
FIGURE 54 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.